# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-01T23:00:03.685311
**Route:** OpenRouter + LaTeX
**Tokens:** 29532 in / 896 out
**Response SHA256:** 39cb067525d9fafc

---

I reviewed the draft for fatal errors in the four mandated categories (Data-Design Alignment, Regression Sanity, Completeness, Internal Consistency). I checked all tables and appendix materials for the specific class of fatal problems you asked me to catch.

Findings (summary)
- I found no fatal errors. Data coverage, treatment timing, and the construction of the treatment indicator are consistent throughout (treatment in‑force dates are all ≤ the May 2017 referendum outcome). Post‑treatment/cohort coding issues (e.g., Basel‑Stadt having no treated–control border and being excluded from RDD / cohort-specific CSA where appropriate) are acknowledged and handled consistently in the text and appendix.  
- All regression outputs in the main tables show plausible coefficients and standard errors (no gigantic or negative SEs, no |coefficients| > 100, no R² outside [0,1], no "NA/TBD/XXX" placeholders). Sample sizes (N) and SEs are reported in regression tables or accompanying notes.  
- The paper documents diagnostics (McCrary, covariate balance, bandwidth sensitivity, donut RDD), provides robustness checks, and flags limitations where appropriate (language measurement at canton level, limited power with few treated cantons).  
- Numbers cited in the text match the tables/figures I checked (e.g., OLS and RDD point estimates, SEs, bandwidths). Where caveats apply (placebo tests run on pre-correction vs corrected samples), the text states this limitation explicitly.

Because your instruction framed my role to flag only fatal errors of the specific types listed, and I found none, I conclude the draft passes this fatal-error review.

ADVISOR VERDICT: PASS